dc.contributor.advisor | Afrose, Afrina | |
dc.contributor.author | Rima, Fouzia Sultana | |
dc.date.accessioned | 2024-12-15T06:26:13Z | |
dc.date.available | 2024-12-15T06:26:13Z | |
dc.date.copyright | 2022 | |
dc.date.issued | 2022-04 | |
dc.identifier.other | ID 16346021 | |
dc.identifier.uri | http://hdl.handle.net/10361/24920 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 51-59). | |
dc.description.abstract | The Covid-19 pandemic has posed a critical threat to global success. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can produce negative results, including asymptomatic respiratory defilement, mild flu-like disease, and peculiar lung sickness. The need for comprehensive worldwide reconnaissance frameworks to identify and follow new variants was noted by members. Right now, variants are, for the most part, found in countries with solid genomic reconnaissance limits, raising the likelihood that risky variations could arise without being trapped in high-rate settings with restricted genome sequencing limits. To guarantee broad observation inclusion, and overall testing approach is required. Various ongoing investigations tending to the biological underpinnings of COVID-19 and its responsiveness to treatment might give the premise to new applicant qualities. To test exact models of connection among numerous hereditary variations between genetic hereditary varieties and openness, hereditary affiliation examinations require a thorough plan and vigorous factual apparatuses. | en_US |
dc.description.statementofresponsibility | Fouzia Sultana Rima | |
dc.format.extent | 59 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | COVID-19 variants | en_US |
dc.subject | Respiratory | en_US |
dc.subject | Genome | en_US |
dc.subject | Treatment | en_US |
dc.subject.lcsh | Covid-19--Treatment. | |
dc.title | A comprehensive study on different variants of SARS-CoV-2 and its impact on human body | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | School of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |